Acadia, sure are being tight lipped about both trials. From my experience, this is not the usual form in P2/P3 trials.
Companies are usually bending over backwards to keep investors informed of progress - enrolment timeline (targets and actual), (no) adverse reactions, (few) withdrawals, overall cohort stats (probably not applicable here) etc.
The big one here is the number of patients rolling over into LILAC. That would be of huge interest to investors, but ACADIA has decided to keep us in the dark.
They are certainly not trying to sell it.
- Forums
- ASX - By Stock
- Where's the bottom?
Acadia, sure are being tight lipped about both trials. From my...
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.22 |
Change
0.450(2.17%) |
Mkt cap ! $2.705B |
Open | High | Low | Value | Volume |
$20.76 | $21.43 | $20.70 | $7.892M | 373.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 596 | $21.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.26 | 1054 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3443 | 21.180 |
2 | 1077 | 21.160 |
1 | 1005 | 21.150 |
2 | 5900 | 21.130 |
2 | 1882 | 21.110 |
Price($) | Vol. | No. |
---|---|---|
21.260 | 1054 | 1 |
21.300 | 1270 | 2 |
21.350 | 1077 | 2 |
21.370 | 194 | 1 |
21.430 | 1005 | 1 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
$21.24 |
  |
Change
0.450 ( 2.73 %) |
|||
Open | High | Low | Volume | ||
$20.76 | $21.42 | $20.73 | 102057 | ||
Last updated 15.59pm 28/03/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online